(Middle) Cells were treated as described in the top panel except that the GARIg was not attached to B chain. (Bottom) Cells were treated as described in the top panel except that GARIg + 1% free B chain was used instead of the GARIg-B. This is one representative experiment of six.
per molecule of antibody and was contaminated with <1% (and usually undetectable levels) of free A or B chains. Alternatively, F(ab')2 fragments were reduced, desahed on Sephadex G-25, and reacted with a 100-fold molar excess of 5,5'-dithiobis(2-nitrobenzoic acid) (Eilman's reagent). Contamination of F(ab') by F(ab')~ ranged from undetectable levels to ~0.1%. The F(ab')-Ellman's was reacted with A chain and the F(ab')-A IT was purified as described previously (9) . F(ab')-A chain contained one A chain per molecule of F(ab').
Evaluation of IT.
IT were assessed for the presence of active antibody and either A or B chain by a solid phase RIA (3, 9) and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 7% slab gels stained with silver (14) . (9) . At least nine wells of untreated cells were included as controls for each treatment group. The percent reduction in [3H]leucine incorporation as compared with the controls was used as the assessment of killing. (Fig. 1 bottom) , no potentiation of the killing by RAHIg-A was observed. These experiments demonstrate that the potentiation of killing is dependent upon the covalent attachment of the B chain to the secondary antibody. An irrelevant secondary IT (GA-OVA-B) was ineffective at potentiating killing by the RAHIg-A (data not shown). In addition, an irrelevant primary IT (RA-OVA-A) or antibody (RAHIg) followed by the GARIg-B did not inhibit protein synthesis (data not shown). Fig. 2 , F(ab') fragments of RAHIg-A were highly toxic to Daudi cells, confirming earlier reports (15, 16) . The titration curves using F(ab')-RAHIg-A chains and intact RAHIg-A were virtually identical. This was unexpected since the F(ab') fragments, in contrast to intact antibody, should not effectively cross- 
Results

Ability of GARIg-B to Potentiate the Killing of
Ability of A Chain-Containing F(ab') Fragments of RAHIg to Kill Daudi Cells. As seen in
Ability of GARIg-B to Potentiate the Killing by F~ab') Fragments of RAHIg-A.
As shown in Fig. 3 , top, nontoxic concentrations of the F(ab')-RAHIg-A caused only a slight reduction in protein synthesis, and none of the concentrations of the GARIg-B were inhibitory. However, when cells were treated with a nontoxic concentration of F(ab')-RAHIg-A, washed, and treated with different amounts Fig. 1 for experimental details. In this experiment, the F(ab')-RAHIg-A (final concentration, 7.2 x 10 -9 M) was used in place of the intact RAHIg-A (Fig. I) . This is one representative experiment of four. FIGURE 4. The effect of delaying the time of addition of GARIg-B on the potentiation of the killing of Daudi ,cells by F(ab') RAHIg-A. Daudi cells were treated with a nontoxic concentration of F(ab )-RAHIgoA (7.2 × 10-SM) as described in Fig. 1 . The washed cells were incubated at 37 °C in complete medium for the indicated time intervals before being washed and treated with GARIg-B (final concentration, 2.5 x 10 -s M), as described in Fig. 1 . Cells were washed, cultured, and harvested as described in Fig. 1 . Results are presented as the percentage of potentiation obtained when GARIg-B addition was not delayed. This is one representative experiment of three.
of GARIg-B, there was significant potentiation of cytotoxicity. This potentiation was not observed with GARIg (Fig. 3, middle) or GARIg mixed with 1% B chains (Fig. 3, bottom) .
Effect of the Time Interval Between the Addition of the Primary and Secondary IT on In Vitro Killing of the Daudi
Cells. An important objective was to demonstrate that F(ab') fragments of RAHIg-A could remain on the cell surface so that GARIg-B could kill such cells when administered after an interval of several hours. Therefore, cells were treated for 15 min at 4 o C with nontoxic concentrations of F(ab')-RAHIg-A, washed, and cultured at 37°C for various time intervals. Cells were then washed and treated for 15 min at 4°C with the GARIg-B, washed, and cultured at 37°C for 22 h. As seen in Fig. 4 , the effectiveness of potentiation with increasing time intervals between treatments with the F(ab')-RAHIg-A and the GARIg-B decreased in a linear fashion. 50% of the control potentiation was observed at an interval of 5 h but no potentiation was observed after an interval of 10 h.
Discussion
Three approaches have been used in vitro to exploit the function of the B chain in potentiating killing by ricin A-IT: (a) the use of ricin-containing IT in which the lectin-binding site of the ricin is sterically blocked by its binding to antibody (17) ; (b) the addition of free B chains to A-IT (7, 18) ; and (c) the addition of B-IT to A-IT in which both IT are directed against the same cell surface molecule (9) . Such B-IT have greatly reduced lectin-binding affinities (9) .
The present results have established the feasibility of using B-IT reactive with the univalent antibody of the A-IT to potentiate its specific toxicity. Furthermore, significant potentiation can be achieved after an interval of ~5 h.
Full toxicity is achieved by the union of two different molecular species, only one of which, F(ab')-A chain, should be toxic to the reticuloendothelial system (RES). Furthermore, FOb') fragments of the A-IT should not bind to Fc receptors on nontarget tissue. Hence, it should be possible to mark target cells in vivo with this IT. Since F(ab') fragments are not reabsorbed by the kidney, the serum half-life is extremely short and 5 h later much of the excess F(ab')-A chain should have been excreted (19). At this time, B-IT directed to determinants on the F(ab') fragments could be administered. B-IT have little or no inherent toxicity. However, their uptake by target cells coated with the F(ab')-A chain IT should result in potentiation of specific toxicity.
There are several potential obstacles which must be overcome before using this strategy in vivo. 
Summary
In vitro killing of the human Daudi cell line by either univalent [F(ab')] or divalent (IgG) forms of rabbit anti-human Ig (RAHIg) coupled to ricin A chain can be specifically potentiated by a "piggyback" treatment with ricin B chain coupled to goat anti-rabbit Ig (GARIg). When cells are treated with univalent immunotoxin (IT) [F(ab') RAHIg-A] and then cultured, IT can be detected on the cell surface for at least 5 h, since GARIg-B can still enhance killing at this time. These results provide a strategy for in vivo use of A chain-and B chaincontaining IT.
